These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
699 related articles for article (PubMed ID: 16718347)
21. Relationships in Alzheimer's disease between the extent of Abeta deposition in cerebral blood vessel walls, as cerebral amyloid angiopathy, and the amount of cerebrovascular smooth muscle cells and collagen. Tian J; Shi J; Smallman R; Iwatsubo T; Mann DM Neuropathol Appl Neurobiol; 2006 Jun; 32(3):332-40. PubMed ID: 16640651 [TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical study of distribution of apolipoproteins E and D in human cerebral beta amyloid deposits. Navarro A; Del Valle E; Astudillo A; González del Rey C; Tolivia J Exp Neurol; 2003 Dec; 184(2):697-704. PubMed ID: 14769361 [TBL] [Abstract][Full Text] [Related]
23. UV light-induced autofluorescence of full-length Abeta-protein deposits in the human brain. Thal DR; Ghebremedhin E; Haass C; Schultz C Clin Neuropathol; 2002; 21(1):35-40. PubMed ID: 11846043 [TBL] [Abstract][Full Text] [Related]
24. Cerebral amyloid angiopathy and its relationship to Alzheimer's disease. Thal DR; Griffin WS; de Vos RA; Ghebremedhin E Acta Neuropathol; 2008 Jun; 115(6):599-609. PubMed ID: 18369648 [TBL] [Abstract][Full Text] [Related]
25. Three-dimensional and fractal analyses of assemblies of amyloid beta protein subtypes [Abeta40 and Abeta42(43)] in canine senile plaques. Miyawaki K; Nakayama H; Matsuno S; Tamaoka A; Doi K Acta Neuropathol; 2002 Mar; 103(3):228-36. PubMed ID: 11907802 [TBL] [Abstract][Full Text] [Related]
26. Amyloid beta plaque-associated proteins C1q and SAP enhance the Abeta1-42 peptide-induced cytokine secretion by adult human microglia in vitro. Veerhuis R; Van Breemen MJ; Hoozemans JM; Morbin M; Ouladhadj J; Tagliavini F; Eikelenboom P Acta Neuropathol; 2003 Feb; 105(2):135-44. PubMed ID: 12536224 [TBL] [Abstract][Full Text] [Related]
27. Concomitant detection of beta-amyloid peptides with N-terminal truncation and different C-terminal endings in cortical plaques from cases with Alzheimer's disease, senile monkeys and triple transgenic mice. Härtig W; Goldhammer S; Bauer U; Wegner F; Wirths O; Bayer TA; Grosche J J Chem Neuroanat; 2010 Sep; 40(1):82-92. PubMed ID: 20347032 [TBL] [Abstract][Full Text] [Related]
29. Apolipoprotein D is a component of compact but not diffuse amyloid-beta plaques in Alzheimer's disease temporal cortex. Desai PP; Ikonomovic MD; Abrahamson EE; Hamilton RL; Isanski BA; Hope CE; Klunk WE; DeKosky ST; Kamboh MI Neurobiol Dis; 2005 Nov; 20(2):574-82. PubMed ID: 15916898 [TBL] [Abstract][Full Text] [Related]
30. Altered Sphingolipid Balance in Capillary Cerebral Amyloid Angiopathy. de Wit NM; Snkhchyan H; den Hoedt S; Wattimena D; de Vos R; Mulder MT; Walter J; Martinez-Martinez P; Hoozemans JJ; Rozemuller AJ; de Vries HE J Alzheimers Dis; 2017; 60(3):795-807. PubMed ID: 27662305 [TBL] [Abstract][Full Text] [Related]
31. Amyloid beta protein starting pyroglutamate at position 3 is a major component of the amyloid deposits in the Alzheimer's disease brain. Harigaya Y; Saido TC; Eckman CB; Prada CM; Shoji M; Younkin SG Biochem Biophys Res Commun; 2000 Sep; 276(2):422-7. PubMed ID: 11027491 [TBL] [Abstract][Full Text] [Related]
32. Topographical distribution of cerebral amyloid angiopathy and its effect on cognitive decline are influenced by Alzheimer disease pathology. Attems J; Quass M; Jellinger KA; Lintner F J Neurol Sci; 2007 Jun; 257(1-2):49-55. PubMed ID: 17306303 [TBL] [Abstract][Full Text] [Related]
33. Relationship of phosphorylated alpha-synuclein and tau accumulation to Abeta deposition in the cerebral cortex of dementia with Lewy bodies. Obi K; Akiyama H; Kondo H; Shimomura Y; Hasegawa M; Iwatsubo T; Mizuno Y; Mochizuki H Exp Neurol; 2008 Apr; 210(2):409-20. PubMed ID: 18164295 [TBL] [Abstract][Full Text] [Related]
34. Capillary CAA and perivascular Aβ-deposition: two distinct features of Alzheimer's disease pathology. Attems J; Yamaguchi H; Saido TC; Thal DR J Neurol Sci; 2010 Dec; 299(1-2):155-62. PubMed ID: 20850138 [TBL] [Abstract][Full Text] [Related]
35. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment. Attems J; Jellinger KA Clin Neuropathol; 2006; 25(6):265-71. PubMed ID: 17140156 [TBL] [Abstract][Full Text] [Related]
36. Neuroinflammation and blood-brain barrier changes in capillary amyloid angiopathy. Carrano A; Hoozemans JJ; van der Vies SM; van Horssen J; de Vries HE; Rozemuller AJ Neurodegener Dis; 2012; 10(1-4):329-31. PubMed ID: 22301467 [TBL] [Abstract][Full Text] [Related]
38. Cerebrovascular disease and the pathophysiology of Alzheimer's disease. Implications for therapy. Weller RO; Cohen NR; Nicoll JA Panminerva Med; 2004 Dec; 46(4):239-51. PubMed ID: 15876980 [TBL] [Abstract][Full Text] [Related]
39. [Sporadic cerebral amyloid angiopathy presenting with dementia and prominent capillary beta-amyloid deposition: a case report]. Yamashita M; Yamamoto T; Yamada M; Okino S; Fujita T Rinsho Shinkeigaku; 2002 Jun; 42(6):530-5. PubMed ID: 12607981 [TBL] [Abstract][Full Text] [Related]
40. Distribution of neprilysin and deposit patterns of Abeta subtypes in the brains of aged squirrel monkeys (Saimiri sciureus). Chambers JK; Kuribayashi H; Ikeda S; Une Y Amyloid; 2010 Jun; 17(2):75-82. PubMed ID: 20462366 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]